Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Cell labeling approaches for tracking stromal vascular fraction fate.

Dadashizadeh G., Wojtowicz-Piotrowski S., Khalaf F., Vlavcheski F., Jeschke MG.

Narrative Review on Immune Modulation, published in Methods (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Methods (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41887345
DOI
10.1016/j.ymeth.2026.03.010
Citations
1

Abstract (original English)

The stromal vascular fraction (SVF) of adipose tissue is a heterogeneous cell population with significant regenerative, paracrine, and immunomodulatory potential, positioning it as a promising therapeutic platform in regenerative medicine and oncology. As SVF-based strategies advance toward preclinical and clinical application, robust methods to label and track transplanted cells have become essential for elucidating their biodistribution, engraftment, survival, differentiation, and functional roles in vivo. A wide spectrum of SVF labeling approaches has been developed, including fluorescent dyes, magnetic and inorganic nanoparticles, radiotracers, and genetically encoded reporters. While these techniques have enabled important biological insights, they differ markedly in sensitivity, stability, biocompatibility, detection modality, and translational feasibility, and each presents distinct methodological limitations such as signal dilution, cytotoxicity, or challenges in distinguishing viable from non-viable cells. In this review, we provide a comprehensive and critical synthesis of current SVF labeling strategies, detailing their mechanistic principles, technical workflows, and applications in in vitro and in vivo tracking studies. Moreover, we highlight the advantages, limitations, and appropriate uses of each modality. By consolidating and evaluating the existing literature,

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansCell TrackingAnimalsFluorescent DyesStaining and LabelingStromal Vascular FractionAdipose TissueStromal CellsNanoparticlesCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research